-
Gland Pharma
2,969.85 3,039.00(%) -
Power Fin.Corpn.
357.70 486.45(%) -
IFCI
107.45 107.45(%) -
Shriram Finance
1,036.40 584.25(%) -
Tata Technolog.
796.45 507.50(%) -
ESDS Software
895.55 895.55(%) -
Lenskart Solut.
694.75 694.75(%) -
Netweb Technol.
5,170.00 2,514.75(%) -
Lumino Inds
122.00 122.00(%) -
Kesar India
1,180.00 1,341.00(%) -
Multi Comm. Exc.
3,287.00 3,479.80(%) -
Tejas Networks
623.90 644.75(%) -
RBL Bank
417.00 417.00(%) -
ICICI AMC
2,960.00 2,528.90(%) -
Polycab India
8,254.00 6,660.50(%) -
New India Assura
234.60 234.60(%) -
Wockhardt
2,107.95 2,420.00(%) -
Angel One
308.20 360.20(%) -
Jindal Worldwide
57.06 57.06(%) -
Lalithaa Jewel
308.55 308.55(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Pondy Oxides & Chemicals Ltd Mining / Minerals / Metals
- Indian Private
- BSE Code : 14229.0
- ISIN : INE063E01061
-
Today’s Low
475.25 -
Today’s High
490.00
-
Open
479.70 -
Perv Close
476.10 -
52W Low
392.20 -
52W High
647.60
Key Indicators
-
P/E(TTM)
24.65
-
Mar.Cap (₹Cr.)
3,644.57
-
Div & Yield %
0.42
-
Book Value(₹)
104.86
-
Debt-Equity Ratio
0.36
-
AGM Date
04-Sep-2026
-
EPS
19.40
-
P/E Ratio
24.65
Financials Ratios
-
Debt-Equity Ratio
0.42
-
Mar.Cap (₹Cr.)
3,644.57
-
RONW (%)
10.26
-
ROCE (%)
13.98
Score Board
-
Equity (₹ in Cr.)
15.26
-
BV (₹)
104.90
-
Sales( ₹ in Cr.)
2,938.65
-
NP (in Cr.)
139.43
-
NP Var(%)
114.0
-
Div%
100.0
-
CPS (₹)
21.00
-
EPS (₹)
18.30
-
Traded Value (₹ in Lakhs)
3,647.62
-
52 Week High
647.60
-
52 Week Low
392.20
-
Price BSE
478.0
-
Price NSE
478.00
-
Market Capital( in Cr.)
3,647.62
-
P/C Ratio
22.70
-
P/E Ratio
26.20
-
Price Vs.BV
18.30
-
04-Aug-2026( 09:37)
Results - Announcements - Pondy... - Pondy Oxides & Chemicals Ltd s...
-
22-Jul-2026( 10:14)
Corporate News - Pondy... - Pondy Oxides & Chemicals will...
-
07-Jul-2026( 07:56)
Market Beat - Pondy... - Pondy Oxides & Chemicals has f...
-
27-May-2026( 11:06)
Corporate News - Board... - Pondy Oxides & Chemicals annou...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)| Particulars(INCOME) | 2026 Mar | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar |
|---|---|---|---|---|---|---|
| INCOME : | ||||||
| Sales Turnover | 2,938.65 | 2,028.27 | 1,525.62 | 1,471.67 | 1,454.80 | 1,004.27 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 2,938.65 | 2,028.27 | 1,525.62 | 1,471.67 | 1,454.80 | 1,004.27 |
| Other Income | 7.18 | 3.66 | 2.75 | 4.25 | 4.63 | 3.32 |
| Stock Adjustments | 20.18 | 10.18 | -7.72 | -0.40 | 30.83 | -16.80 |
| Total Income | 2,966.01 | 2,042.11 | 1,520.65 | 1,475.52 | 1,490.26 | 990.79 |
| EXPENDITURE : | ||||||
| Raw Materials | 2,622.20 | 1,829.32 | 1,346.11 | 1,298.29 | 1,326.19 | 915.50 |
| Power and Fuel Cost | 34.75 | 33.78 | 33.50 | 31.06 | 23.87 | 9.95 |
| Employee Cost | 31.79 | 25.34 | 24.24 | 22.31 | 19.96 | 16.47 |
| Other Manufacturing Expenses | 29.23 | 21.85 | 21.12 | 20.15 | 17.99 | 7.18 |
| Selling and Administration Expenses | 24.00 | 20.69 | 16.43 | 18.24 | 17.91 | 11.78 |
| Miscellaneous Expenses | 5.41 | 2.88 | 1.61 | 1.41 | 2.31 | 2.32 |
| Employee Benefit Expenses | 31.79 | 25.34 | 24.24 | 22.31 | 19.96 | 16.47 |
| Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Expenses | 2,747.38 | 1,933.86 | 1,443.00 | 1,391.46 | 1,408.22 | 963.21 |
| Operating Profit | 218.63 | 108.24 | 77.65 | 84.06 | 82.03 | 27.59 |
| Interest | 11.28 | 12.33 | 16.80 | 8.24 | 8.69 | 5.42 |
| Gross Profit | 207.35 | 95.91 | 60.85 | 75.82 | 73.34 | 22.17 |
| Depreciation | 20.94 | 11.18 | 9.22 | 10.06 | 8.99 | 8.39 |
| Profit Before Tax | 186.41 | 84.73 | 51.63 | 65.76 | 64.35 | 13.78 |
| Current Tax | 57.63 | 21.11 | 13.30 | 17.05 | 17.05 | 3.70 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -9.95 | -1.44 | -1.19 | -0.49 | -0.94 | -0.70 |
| Reported Net Profit | 138.73 | 65.06 | 39.52 | 49.20 | 48.25 | 10.78 |
| Extraordinary Items | -0.70 | 0.00 | 0.28 | -0.29 | 0.06 | -0.07 |
| Adjusted Net Profit | 139.43 | 65.06 | 39.24 | 49.49 | 48.19 | 10.85 |
| Adjustment below Net Profit | -0.94 | -0.28 | -0.16 | -0.25 | -0.08 | -0.18 |
| P & L Balance brought forward | 299.10 | 244.26 | 214.65 | 173.55 | 131.53 | 121.75 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 17.65 | 9.95 | 9.74 | 7.85 | 6.14 | 0.82 |
| P & L Balance carried down | 419.24 | 299.10 | 244.26 | 214.65 | 173.55 | 131.53 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 100.00 | 70.00 | 50.00 | 50.00 | 50.00 | 25.00 |
| Dividend Per Share(Rs) | 2.00 | 3.50 | 5.00 | 5.00 | 5.00 | 2.50 |
| Earnings Per Share-Unit Curr | 45.47 | 23.13 | 31.33 | 42.32 | 83.01 | 18.54 |
| Earnings Per Share(Adj)-Unit Curr | 18.19 | 9.25 | 6.27 | 8.46 | 8.30 | 1.85 |
| Book Value | 262.15 | 207.07 | 265.02 | 218.62 | 358.11 | 277.55 |
| Book Value(Adj)-Unit Curr | 104.86 | 82.83 | 53.00 | 43.72 | 35.81 | 27.76 |
